MACROGENICS INC — Director's Dealing 2025

Feb 19, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2025-02-15

Reporting Person: Eck Stephen L. (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-15	Common Stock	M	16665	—	Acquired	34319	Direct
2025-02-15	Common Stock	F	4942	$2.56	Disposed	29377	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-15	Restricted Stock Unit	$0	M	16665	Disposed		Common Stock (16665)	Direct

Footnotes

F1: On February 15, 2023, the reporting person was granted 50,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.